Search by Blog
Read by Category

Your healing journey continues beyond this blog

Find the right products for better recovery at online store
Cart Image
Velfiz Edge CHG

Intravenous catheterization is a common practice for administering fluids directly into the blood stream. It is often associated with a lethal and a very frequent complication of Catheter-related bloodstream infection (CRBSI).

Catheter-related bloodstream infections (CRBSI) are defined as the presence of bacteraemia originating from an intravenous catheter. CRBSIs are a leading cause of nosocomial infections associated with morbidity, mortality, and cost. 

Managing CRBSI:

The general way of managing CRBSI associated with any local or systemic inflammation is to remove the catheters from patients and initiate antibiotic therapy empirically. Chlorhexidine gluconate impregnated transparent dressings are being used to cover and protect catheter sites and secure devices to the skin. 

Do You Know?
Chlorhexidine belongs to the group of antiseptic antibacterial agents. It is primarily used to cleanse the skin after an injury, before surgery, or before an injection. Chlorhexidine works by killing (bactericidal) or preventing the growth of bacteria (bacteriostatic) on the skin. It can even be used to clean the hands before a procedure.

We present Velfix® -Edge+CHG, a Chlorhexidine Gluconate IV Securement Dressing. It comprises of a Stabilization Non-Woven Border, Antimicrobial Protection, High MVTR Transparent Film, a Notch, Securement Tape Strips and Documentation Label.

  • Antimicrobial Protection offered by Chlorhexidine Gluconate which is effective in protecting against catheter tip colonization. As per the study published in The American Journal of Medicine, “Chlorhexidine has a broad spectrum of antibacterial activity against Gram-positive bacteria, Gram-negative bacteria, aerobic bacteria, anaerobic bacteria and fungi, and the use of chlorhexidine for skin disinfection in ICU patients reduces the spread of microbes and the incidence of CRBSIs”.
  • Stabilization Non-Woven Border maximizes securement, breathability & wear time of the dressing.
  • High MVTR Transparent Film acts as a waterproof sterile barrier to external contaminants. MVTR is Moisture Vapour Transmission Rate is the measure of permeability for vapour barriers. Velfix® -Edge+CHG is a high MVTR dressing which allows excess moisture to evaporate through the dressing while maintaining proper securement.
  • Velfix® -Edge+CHG comes with 2 Securement Tape Strips to enhance the securement while promoting consistent application.
  • A Notch is provided for opening to host the cannula’s port & reduces risk of catheter dislodgement.
  • Documentation Label is a Pre-printed label to note dressing changes.

PROPERTIES & BENEFITS:

  • Highly conformable to provide solutions for difficult catheter and IV sites
  • Window frame design of Velfix® -Edge+CHG allows continuous observation of IV site
  • Offers waterproof sterile barrier to external contaminants because of high MVTR transparent film
  • Stabilization non-woven borders maximize securement, breathability & wear time
  • Notched design discourages edge lift
  • Velfix® -Edge+CHG is very easy to handle with gloved hands allowing single handed application
  • Made with a premium 30 μ high MVTR transparent Polyurethane film
  • EO Sterile
  • Chlorhexidine gluconate (CHG) aids in infection reduction.
  • Conforming & durable
  • Leaves no adhesive residue on skin post removal
USE: Velfix® -Edge+CHG can be used for the securement of Central Venous Catheters, IV Catheter sites, Dialysis catheters, Hickman/ Broviac catheters, Epidural catheters, Arterial catheters, Short peripheral and midline venous catheters. Velfix® -Edge+CHG comes in various customized sizes with varying CHG gel pad sizes for different IV devices.
Visit www.dattmedi.com for more infomation.
Share:
Recent Blogs

In the realm of wound care, continuous advancements are constantly improving the way we treat and manage various types of wounds. Among the latest innovations, Velseal® -T Disc has emerged as a game-changer. This revolutionary product offers an effective and convenient solution for promoting wound healing and enhancing patient comfort.

Understanding Velseal® -T Disc

It is a cutting-edge wound care product designed to optimize the healing process while minimizing discomfort for patients. Velseal® -T Disc promotes haemostasis by absorbing the blood and accumulates clotting factor within the voids and initiate the clotting by interaction with Thrombin, Calcium chloride and Tranexamic acid.

Key Features and Benefits:

1. Advanced Composition:

It is composed of high-quality materials that offer excellent absorption and retention capacities, reducing the risk of maceration and infection. However, it does not provide moisture balance or directly contribute to wound healing.

2. Easy Application:

Thee disc-shaped design of Velseal® -T Disc allows for simple and hassle-free application. Its non-adherent nature eliminates the need for additional fixation methods, providing a secure and comfortable fit. The dressing is available in various sizes to accommodate different wound types and locations.

3. Enhanced Patient Comfort:

It prioritizes patient comfort by minimizing pain and trauma during dressing changes. The non-adherent surface prevents the dressing from sticking to the wound bed, reducing discomfort and potential damage to healing tissue.

4. Cost-Effective Solution:

It offers a cost-effective wound care solution, as it requires no dressing changes. A single application helps in achieving complete hemostasis, contributing to overall healthcare cost savings. Its durability and prolonged wear time further enhance its cost-effectiveness.

Clinical Efficacy and Evidence

The product has undergone rigorous testing and evaluation to validate its clinical efficacy. Clinical studies have demonstrated its effectiveness in promoting faster wound healing, reducing pain, and minimizing complications such as infection. These studies highlight the dressing’s superior moisture management capabilities and its ability to facilitate granulation tissue formation, resulting in improved patient outcomes.

In the rapidly evolving field of wound care, the Velseal® -T Disc stands out as a remarkable innovation. Its unique composition, easy application, and patient-centric design make it a valuable addition to any healthcare setting. With its demonstrated clinical efficacy and cost-effectiveness, this advanced dressing offers a promising solution for healthcare professionals and patients alike. By leveraging the benefits of Velseal® -T Disc, healthcare providers can enhance wound healing outcomes and improve the overall quality of care for patients with acute or chronic wounds.

In our fast-paced and demanding modern world, it has become increasingly crucial to prioritize our health and well-being. Among the myriad of health concerns affecting millions worldwide, cancer stands as one of the most significant challenges we face. However, with advances in medical science, early detection has emerged as a powerful tool in the fight against this devastating disease. In this blog, we will explore the importance of early cancer detection, shed light on screening guidelines, and emphasize the necessity of regular screenings for various types of cancer.

The Impact of Early Cancer Detection: Early detection plays a pivotal role in improving cancer outcomes and significantly increasing the chances of successful treatment. When cancer is detected in its early stages, before it has metastasized, treatment options are often less aggressive and more effective. Moreover, early detection significantly enhances survival rates, underscoring the vital importance of regular screenings for individuals.

Screening Guidelines for Different Types of Cancer:

Breast Cancer:

Among women, breast cancer is one of the most prevalent forms of the disease. The American Cancer Society advises that women aged 40 and above should undergo annual mammograms for breast cancer screening. However, individual risk factors may warrant earlier screenings or additional tests.


Colorectal Cancer:

Affecting both men and women, colorectal cancer ranks as the third most common cancer globally. Screening for colorectal cancer typically begins at the age of 45. Methods such as colonoscopy, sigmoidoscopy, and stool-based tests are employed to detect abnormal growths or cancerous cells in the colon or rectum.

Cervical Cancer:

Regular screenings and human papillomavirus (HPV) vaccination can prevent cervical cancer. The American Cancer Society recommends cervical cancer screening for individuals with a cervix starting at the age of 25. This can be achieved through a Pap test, an HPV test, or a combination of both.

Lung Cancer:

As the leading cause of cancer-related deaths worldwide, lung cancer poses a significant threat. For individuals at high risk, such as current or former smokers, low-dose computed tomography (LDCT) scans are recommended. Screening should commence at the age of 50 and continue until age 80, or as long as the individual is in good health.


Prostate Cancer:

Primarily affecting men, prostate cancer typically develops in older individuals. The American Cancer Society advises men to discuss the potential benefits and risks of prostate cancer screening with their healthcare provider. Screening options include prostate-specific antigen (PSA) blood tests and digital rectal exams.

Early cancer detection can save lives by enabling more effective treatment options and improving survival rates. By adhering to the recommended screening guidelines for different types of cancer, individuals can take proactive steps towards their health and potentially detect cancer in its early stages.

Through raising awareness, educating the public, and advocating for regular screenings, we can work together to alleviate the burden of cancer and enhance overall healthcare outcomes. Remember, prevention and early detection are the keys to triumphing over cancer. This strategic stance promises extended lives, improved outcomes, and a brighter future for all, underscoring the vital role of early cancer detection as a beacon of hope in a world where health is paramount.

×